73470-46-9 Usage
General Description
Tert-butyl (1-amino-2-methyl-1-oxopropan-2-yl)carbamate is an organic chemical compound with the molecular formula C7H15N3O3. It is a carbamate derivative with a tert-butyl group attached to the nitrogen atom, and an amino and oxopropan-2-yl groups attached to the carbon atom. tert-Butyl (1-amino-2-methyl-1-oxopropan-2-yl)carbamate is commonly used as a protecting group in peptide synthesis to block the amino group of specific amino acids, allowing for selective manipulation of peptide chains during synthesis. It is also used in the pharmaceutical industry for the synthesis of various pharmaceuticals and as a reagent in organic chemical reactions. Tert-butyl (1-amino-2-methyl-1-oxopropan-2-yl)carbamate is a colorless solid with a mild odor and is considered to be stable under normal conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 73470-46-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,4,7 and 0 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 73470-46:
(7*7)+(6*3)+(5*4)+(4*7)+(3*0)+(2*4)+(1*6)=129
129 % 10 = 9
So 73470-46-9 is a valid CAS Registry Number.
73470-46-9Relevant articles and documents
ALKYLBORONIC ACIDS AS ARGINASE INHIBITORS
-
Page/Page column 103, (2020/08/22)
Provided are alkylboronic acids as arginase inhibitors represented by formula (I), or a pharmaceutically acceptable salt, stereoisomer, tautomer, or prodrug thereof and a pharmaceutical composition comprising said compounds.
HETEROCYCLIC COMPOUNDS AS ARGINASE INHIBITORS
-
Page/Page column 68, (2019/07/13)
The present invention relates to heterocyclic compounds as arginase inhibitors, in particular to a compound represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer or tautomer, or prodrug thereof and a pharmaceutical composition comprising said compound.
PYRIDIN- 2 -AMIDES USEFUL AS CB2 AGONISTS
-
Page/Page column 80, (2013/02/27)
The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.